<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6385">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01696903</url>
  </required_header>
  <id_info>
    <org_study_id>SKARV-GLH-001</org_study_id>
    <secondary_id>KI-DSGE-DUAS</secondary_id>
    <nct_id>NCT01696903</nct_id>
  </id_info>
  <brief_title>Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy</brief_title>
  <official_title>Clinical Randomized Trial Investigating a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy in Patients With a High Risk for Postoperative Pancreatic Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <authority>Sweden: The National Board of Health and Welfare</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreaticoduodenectomy is a surgical procedure for removing cancer in the pancreas, the
      bile system or the duodenum that is associated with a high rate of complications. The study
      wants to investigate whether a new technique to reconstruct the joint between the pancreatic
      gland and the short bowel can reduce the rate of severe complications after this complex
      surgical procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreaticoduodenectomy is a complex surgical procedure for radically resecting tumors in
      the pancreatic head, distal bile duct or duodenum. Postoperative pancreatic fistula is the
      main contributor of severe postoperative morbidity after pancreaticoduodenectomy.
      Characteristics of the pancreatic gland like soft pancreatic consistency and small
      pancreatic main duct predispose for the postoperative fistula development. In high risk
      patients, the risk of suffering from associated postoperative morbidity is 50 percent which
      is considered unacceptable high. The aim of the current trial is to investigate whether a
      new anastomosing technique for the pancreaticojejunostomy can reduce the incidence of
      associated postoperative morbidity in patients undergoing pancreaticoduodenectomy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Clinically Relevant Postoperative Pancreatic Fistula</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Postoperative pancreatic fistula as defined by the International Study Group of Pancreatic Fistula</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Associated postoperative morbidity</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Postoperative pancreatic fistula and abscesses or fluid collections adjacent to the pancreaticojejunostomy constitute a morbidity event; pancreaticojejunostomy-associated morbidity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Severity of postoperative complications</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The severity of postoperative complications as classified by the classification system of postoperative complications adopted for pancreatic surgery.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pancreatic Fistula</condition>
  <arm_group>
    <arm_group_label>Conventional anastomosis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional anastomosis: The pancreaticojejunostomy is carried out in a traditional way according to &quot;Cattel's duct-to-mucosa technique&quot;.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Novel anastomosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Novel anastomosis: This the active comparator to the conventional anastomosis. A new pancreaticojejunostomy technique is used for the reconstruction. The pancreas is intubated into the jejunum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreaticojejunostomy technique</intervention_name>
    <description>The anastomosis between jejunum and remnant pancreas has a pivotal impact on the incidence of postoperative pancreatic fistula. by this novel technique the remnant pancreas is intubated into the jejunum without extensive manipulation.</description>
    <arm_group_label>Novel anastomosis</arm_group_label>
    <other_name>Pancreaticojejunal anastomosis</other_name>
    <other_name>Intubating pancreaticojejunostomy</other_name>
    <other_name>Dunking pancreaticojejunostomy</other_name>
    <other_name>pancreatojejunostomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective pancreaticoduodenectomy

          -  Pancreatic gland with high risk criteria for associated postoperative morbidity

        Exclusion Criteria:

          -  Patients do not accept participation

          -  Pancreatic gland with intermediate or low risk criteria for associated postoperative
             morbidity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Ansorge, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ralf Segersvärd, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Ansorge, MD, PhD</last_name>
    <phone>+46734098881</phone>
    <email>christoph.ansorge@karolinska.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ralf Segersvärd, MD, PhD</last_name>
    <email>ralf.segersvard@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Upper Abdominal Surgery, Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gasslander, MD, PhD</last_name>
      <email>thomas.gasslander@liu.se</email>
    </contact>
    <investigator>
      <last_name>Thomas Gasslander, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bergthor Björnsson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Surgical gastroenterology, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Ansorge, MD</last_name>
      <email>christoph.ansorge@karolinska.se</email>
    </contact>
    <contact_backup>
      <last_name>Ralf Segersvärd, MD, PhD</last_name>
      <email>ralf.segersvard@ki.se</email>
    </contact_backup>
    <investigator>
      <last_name>Christoph Ansorge, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Blomberg, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://ki.se</url>
    <description>Issuer organization</description>
  </link>
  <link>
    <url>http://www.karolinska.se</url>
    <description>Investigation site</description>
  </link>
  <link>
    <url>http://www.sahlgrenska.se</url>
    <description>Investigation site</description>
  </link>
  <link>
    <url>http://www.lio.se</url>
    <description>Investigation site</description>
  </link>
  <reference>
    <citation>Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005 Jul;138(1):8-13. Review.</citation>
    <PMID>16003309</PMID>
  </reference>
  <reference>
    <citation>Ansorge C, Strömmer L, Andrén-Sandberg Å, Lundell L, Herrington MK, Segersvärd R. Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg. 2012 Aug;99(8):1076-82. doi: 10.1002/bjs.8784. Epub 2012 May 4.</citation>
    <PMID>22556164</PMID>
  </reference>
  <reference>
    <citation>Kennedy EP, Yeo CJ. Dunking pancreaticojejunostomy versus duct-to-mucosa anastomosis. J Hepatobiliary Pancreat Sci. 2011 Aug 16. [Epub ahead of print]</citation>
    <PMID>21845376</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 6, 2013</lastchanged_date>
  <firstreceived_date>September 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christoph Ansorge</investigator_full_name>
    <investigator_title>Christoph Ansorge, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Postoperative pancreatic fistula</keyword>
  <keyword>Pancreatic texture</keyword>
  <keyword>Pancreatic duct diameter</keyword>
  <keyword>Pancreatic consistency</keyword>
  <keyword>Pancreaticoduodenectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
